128 related articles for article (PubMed ID: 17035012)
1. ATP-conjugated peptide inhibitors for calmodulin-dependent protein kinase II.
Ahn DR; Han KC; Kwon HS; Yang EG
Bioorg Med Chem Lett; 2007 Jan; 17(1):147-51. PubMed ID: 17035012
[TBL] [Abstract][Full Text] [Related]
2. A novel highly specific and potent inhibitor of calmodulin-dependent protein kinase II.
Ishida A; Kameshita I; Okuno S; Kitani T; Fujisawa H
Biochem Biophys Res Commun; 1995 Jul; 212(3):806-12. PubMed ID: 7626114
[TBL] [Abstract][Full Text] [Related]
3. Influence of a mutation in the ATP-binding region of Ca2+/calmodulin-dependent protein kinase II on its interaction with peptide substrates.
Praseeda M; Pradeep KK; Krupa A; Krishna SS; Leena S; Kumar RR; Cheriyan J; Mayadevi M; Srinivasan N; Omkumar RV
Biochem J; 2004 Mar; 378(Pt 2):391-7. PubMed ID: 14558884
[TBL] [Abstract][Full Text] [Related]
4. Effect of the structure of adenosine mimic of bisubstrate-analog inhibitors on their activity towards basophilic protein kinases.
Enkvist E; Kriisa M; Roben M; Kadak G; Raidaru G; Uri A
Bioorg Med Chem Lett; 2009 Nov; 19(21):6098-101. PubMed ID: 19800227
[TBL] [Abstract][Full Text] [Related]
5. Bisubstrate analog probes for the insulin receptor protein tyrosine kinase: molecular yardsticks for analyzing catalytic mechanism and inhibitor design.
Hines AC; Parang K; Kohanski RA; Hubbard SR; Cole PA
Bioorg Chem; 2005 Aug; 33(4):285-97. PubMed ID: 16023488
[TBL] [Abstract][Full Text] [Related]
6. Directed modulation of protein kinase C isozyme selectivity with bisubstrate-based inhibitors.
van Wandelen LT; van Ameijde J; Mady AS; Wammes AE; Bode A; Poot AJ; Ruijtenbeek R; Liskamp RM
ChemMedChem; 2012 Dec; 7(12):2113-21. PubMed ID: 23139239
[TBL] [Abstract][Full Text] [Related]
7. Bisubstrate inhibitors of protein kinases: from principle to practical applications.
Lavogina D; Enkvist E; Uri A
ChemMedChem; 2010 Jan; 5(1):23-34. PubMed ID: 19774589
[TBL] [Abstract][Full Text] [Related]
8. Thermodynamics of calmodulin trapping by Ca2+/calmodulin-dependent protein kinase II: subpicomolar Kd determined using competition titration calorimetry.
Tse JK; Giannetti AM; Bradshaw JM
Biochemistry; 2007 Apr; 46(13):4017-27. PubMed ID: 17352496
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of autophosphorylation of epidermal growth factor receptor by a small peptide not employing an ATP-competitive mechanism.
Abe M; Kuroda Y; Hirose M; Kato M; Murakami M; Watanabe Y; Nakano M; Handa T
Biopolymers; 2008 Jan; 89(1):40-51. PubMed ID: 17849478
[TBL] [Abstract][Full Text] [Related]
10. Mechanism-based design of a protein kinase inhibitor.
Parang K; Till JH; Ablooglu AJ; Kohanski RA; Hubbard SR; Cole PA
Nat Struct Biol; 2001 Jan; 8(1):37-41. PubMed ID: 11135668
[TBL] [Abstract][Full Text] [Related]
11. Development of selective bisubstrate-based inhibitors against protein kinase C (PKC) isozymes by using dynamic peptide microarrays.
Poot AJ; van Ameijde J; Slijper M; van den Berg A; Hilhorst R; Ruijtenbeek R; Rijkers DT; Liskamp RM
Chembiochem; 2009 Aug; 10(12):2042-51. PubMed ID: 19618415
[TBL] [Abstract][Full Text] [Related]
12. Identification of polyoxometalates as nanomolar noncompetitive inhibitors of protein kinase CK2.
Prudent R; Moucadel V; Laudet B; Barette C; Lafanechère L; Hasenknopf B; Li J; Bareyt S; Lacôte E; Thorimbert S; Malacria M; Gouzerh P; Cochet C
Chem Biol; 2008 Jul; 15(7):683-92. PubMed ID: 18635005
[TBL] [Abstract][Full Text] [Related]
13. Anticoccidial kinase inhibitors: identification of protein kinase targets secondary to cGMP-dependent protein kinase.
Donald RG; Zhong T; Wiersma H; Nare B; Yao D; Lee A; Allocco J; Liberator PA
Mol Biochem Parasitol; 2006 Sep; 149(1):86-98. PubMed ID: 16765465
[TBL] [Abstract][Full Text] [Related]
14. Truncation and optimisation of peptide inhibitors of cyclin-dependent kinase 2-cyclin a through structure-guided design.
Kontopidis G; Andrews MJ; McInnes C; Plater A; Innes L; Renachowski S; Cowan A; Fischer PM
ChemMedChem; 2009 Jul; 4(7):1120-8. PubMed ID: 19472269
[TBL] [Abstract][Full Text] [Related]
15. Stepwise combinatorial evolution of Akt bisubstrate inhibitors.
Lee JH; Kumar S; Lawrence DS
Chembiochem; 2008 Mar; 9(4):507-9. PubMed ID: 18224646
[No Abstract] [Full Text] [Related]
16. Allosteric lariat peptide inhibitors of Abl kinase.
Bharathikumar VM; Barreto K; Decoteau JF; Geyer CR
Chembiochem; 2013 Nov; 14(16):2119-25. PubMed ID: 24030821
[TBL] [Abstract][Full Text] [Related]
17. Calcium-calmodulin-dependent protein kinase II phosphorylation modulates PSD-95 binding to NMDA receptors.
Gardoni F; Polli F; Cattabeni F; Di Luca M
Eur J Neurosci; 2006 Nov; 24(10):2694-704. PubMed ID: 17156196
[TBL] [Abstract][Full Text] [Related]
18. Kinetic mechanism and inhibitor characterization for c-jun-N-terminal kinase 3alpha1.
Ember B; Kamenecka T; LoGrasso P
Biochemistry; 2008 Mar; 47(10):3076-84. PubMed ID: 18269248
[TBL] [Abstract][Full Text] [Related]
19. Kinase-catalyzed modification of gold nanoparticles: a new approach to colorimetric kinase activity screening.
Wang Z; Lévy R; Fernig DG; Brust M
J Am Chem Soc; 2006 Feb; 128(7):2214-5. PubMed ID: 16478166
[TBL] [Abstract][Full Text] [Related]
20. Calmodulin kinase II inhibition shortens action potential duration by upregulation of K+ currents.
Li J; Marionneau C; Zhang R; Shah V; Hell JW; Nerbonne JM; Anderson ME
Circ Res; 2006 Nov; 99(10):1092-9. PubMed ID: 17038644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
